We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Date
- 2026 (35)
- 2025 (30)
- 2024 (17)
- 2023 (44)
- 2022 (38)
- 2021 (36)
- 2020 (58)
- 2019 (31)
- 2018 (46)
- 2017 (11)
- 2016 (44)
- 2015 (36)
- 2014 (10)
- 2013 (12)
- 2012 (3)
- 2011 (6)
- 2010 (27)
- 2009 (4)
- 2008 (15)
- 2007 (1)
- 2006 (4)
- 2005 (10)
- 2004 (4)
- 2003 (5)
- 2002 (7)
- 2001 (3)
- 2000 (8)
- 1999 (2)
- 1998 (2)
- 1997 (4)
- 1996 (3)
- 1995 (4)
- 1993 (10)
- 1992 (3)
- 1991 (12)
Sponsor content
585 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ALIGEOV 1%/0.5% brinzolamide 1% w/v and timolol 0.5% w/v eye drops.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for JAKAVI ruxolitinib (as phosphate) 5 mg/mL oral solution bottle.
-
Australian Public Assessment Report (AusPAR)Tabrecta (capmatinib) has been approved for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TABRECTA capmatinib (as hydrochloride) 150 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TABRECTA capmatinib (as hydrochloride) 200 mg tablet blister pack.
-
Prescription medicine decision summaryTabrecta has been approved for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation. Tabrecta contains the active ingredient capmatinib.
-
Australian Public Assessment Report (AusPAR)Rhapsido (remibrutinib) has been approved for the treatment of chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamine treatment.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RHAPSIDO remibrutinib 25 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CEAHANI nilotinib 150 mg capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CEAHANI nilotinib 200mg capsules blister pack.